Products for Research Use Only
RegisterLogin

EGFR-IN-139

CAT: 0804-HY-170438Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-170438Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
EGFR-IN-139 (compound PD 18) is an epidermal growth factor receptor (EGFR) inhibitor, with IC50s of 12.88 (wild type), 10.84 (L858R/T790M), 42.68 (L858R/T790M/C797S) nM, respectively. EGFR-IN-139 displays strong anticancer activity against A549 and H1975 cancer cell lines, which are highly expressed EGFR. EGFR-IN-139 has a strong selectivity to cancer cells. EGFR-IN-139 can be used for nonsmall cell lung cancer (NSCLC) research[1].
CAS Number
1574321-31-5
UNSPSC
12352005
Target
EGFR
Related Pathways
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Smiles
O=C(C1=CC=C2OCCOC2=C1)C(O3)=CC4=C3C(C)=NC=C4CN5CC6=C(C=CC=C6)CC5.Cl
Molecular Formula
C27H25ClN2O4
Molecular Weight
476.95
References & Citations
[1]Todsaporn D, et al. Furopyridine Derivatives as Potent Inhibitors of the Wild Type, L858R/T790M, and L858R/T790M/C797S EGFR. J Phys Chem B. 2024 Dec 19;128 (50) :12389-12402.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-119853Bayer A 139
HY-106437-01ELB-139
HY-179411Antifungal agent 139
HY-149388Anticancer agent 139
HY-163301Antitumor agent-139
HY-P0129-01PLP (139-151)
HY-149095Antibacterial agent 139
HY-D0284-01Pigment Yellow 139
HY-P1038[SER140]-PLP (139-151)
HY-P10314[Leu144]-PLP (139-151)

Alternative Products

CatalogName
T204772-01EGFR-IN-139
T70703-01DK-139
T27252-01ELB-139
B2266-1TD-139
sc-65807AChRδ (139)
M12258-01PU-139
BT173009-01TD 139
cyt-843-01IFNG (139)
E-PP-0188-01[Gln144]-PLP (139-151), Q144-PLP (139-151)
E-PP-0216-01[Leu144]-PLP (139-151), L144-PLP (139-151)

Popular Products